Clinical Trial Update: Effect of Ipratropium Bromide on EILO [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ipratropium bromide for exercise-induced laryngeal obstruction; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exercise-induced Laryngeal Obstruction

Drugs mentioned

• IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

Sponsor: Cook Children's Health Care System | Conditions: Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity | Phase 2 | Status: NOT_YET_RECRUITING